Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

August Sigle

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Cancers|June 2, 2021
Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed?August Sigle, Cordula A Jilg, Timur H Kuru, et al.
Oncology Research and Treatment|October 23, 2025
Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate CancerRuth Himmelsbach, Julia Franz, August Sigle, et al.
European Urology Focus|February 21, 2023
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter StudyAugust Sigle, Angelika Borkowetz, Jost von Hardenberg, et al.
AJR. American Journal of Roentgenology|October 15, 2025
PI-RADS Version 2.1 for Prostate MRI Interpretation: Associations of Study Quality and Cancer Detection Metrics-A Systematic Review and Meta-AnalysisAndrea Nedelcu, Benedict Oerther, Alexander Benkendorff, et al.
European Urology Focus|December 11, 2025
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer-Oncological Outcome from Long-term Follow-upRuth Himmelsbach, Simon K B Spohn, Anca-Ligia Grosu, et al.
Urologia Internationalis|April 16, 2024
Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor BoardJakob Michaelis, Ruth Himmelsbach, Patrick Metzger, et al.
European Urology Open Science|December 1, 2025
Validation of Artificial Intelligence-enhanced Stimulated Raman Histopathology for Intraoperative Margin Assessment During Robot-assisted Radical Prostatectomy: Preliminary Results from the ROBOSPEC StudyArif Özkan, Karl-Moritz Schröder, Peter Bronsert, et al.
Frontiers in Oncology|May 31, 2021
Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology ReferenceSimon K B Spohn, Ilias Sachpazidis, Rolf Wiehle, et al.
Frontiers in Oncology|December 17, 2020
Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI-A Correlation Study With Whole Mount Histopathological Information as ReferenceMaria Kramer, Simon K B Spohn, Selina Kiefer, et al.
Frontiers in Oncology|December 15, 2025
Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohortMaximilian Glienke, Ruth Himmelsbach, Max Zirngibl, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Cancers|June 2, 2021
Evaluation of the Ginsburg Scheme: Where Is Significant Prostate Cancer Missed?August Sigle, Cordula A Jilg, Timur H Kuru, et al.
Oncology Research and Treatment|October 23, 2025
Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate CancerRuth Himmelsbach, Julia Franz, August Sigle, et al.
European Urology Focus|February 21, 2023
Prediction of Significant Prostate Cancer in Equivocal Magnetic Resonance Imaging Lesions: A High-volume International Multicenter StudyAugust Sigle, Angelika Borkowetz, Jost von Hardenberg, et al.
AJR. American Journal of Roentgenology|October 15, 2025
PI-RADS Version 2.1 for Prostate MRI Interpretation: Associations of Study Quality and Cancer Detection Metrics-A Systematic Review and Meta-AnalysisAndrea Nedelcu, Benedict Oerther, Alexander Benkendorff, et al.
European Urology Focus|December 11, 2025
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer-Oncological Outcome from Long-term Follow-upRuth Himmelsbach, Simon K B Spohn, Anca-Ligia Grosu, et al.
Urologia Internationalis|April 16, 2024
Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor BoardJakob Michaelis, Ruth Himmelsbach, Patrick Metzger, et al.
European Urology Open Science|December 1, 2025
Validation of Artificial Intelligence-enhanced Stimulated Raman Histopathology for Intraoperative Margin Assessment During Robot-assisted Radical Prostatectomy: Preliminary Results from the ROBOSPEC StudyArif Özkan, Karl-Moritz Schröder, Peter Bronsert, et al.
Frontiers in Oncology|May 31, 2021
Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology ReferenceSimon K B Spohn, Ilias Sachpazidis, Rolf Wiehle, et al.
Frontiers in Oncology|December 17, 2020
Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI-A Correlation Study With Whole Mount Histopathological Information as ReferenceMaria Kramer, Simon K B Spohn, Selina Kiefer, et al.
Frontiers in Oncology|December 15, 2025
Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohortMaximilian Glienke, Ruth Himmelsbach, Max Zirngibl, et al.
Pageof 6